Ignite Creation Date:
2024-05-06 @ 12:42 AM
Last Modification Date:
2024-10-26 @ 10:53 AM
Study NCT ID:
NCT01630746
Status:
COMPLETED
Last Update Posted:
2014-02-10
First Post:
2012-06-26
Brief Title:
A Randomized Double-Blind Multicenter Study to Evaluate the Acid-inhibitory and Dose-response Efficacy of TAK-438 20 mg 40 mg in Patients With Proton Pump Inhibitor PPI - Resistant Erosive Esophagitis
Sponsor:
Takeda
Organization:
Takeda
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2014-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the acid-inhibitory and dose-response efficacy of TAK-438 20 mg 40 mg in patients with PPI-resistant erosive esophagitis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| U1111-1130-9074 | REGISTRY | WHO | None |
| JapicCTI-121882 | REGISTRY | None | None |